Cytokinetics Secures First FDA Approval With Myqorzo Heart Drug
Cytokinetics has reached a defining milestone after the U.S. Food and Drug Administration approved its heart drug Myqorzo for adults with obstructive hypertrophic cardiomyopathy,...
Thermo Fisher launches Alzheimers Disease Registry
Thermo Fisher Scientific Inc., which is regarded as the world leader when it comes to serving science, went on to announce the enrollment of...
Meiji Seika Pharma, MBC BioLabs Drug Discovery Partnership
Meiji Seika Pharma has entered into a strategic collaboration with MBC BioLabs to deepen its global drug discovery innovation partnership and strengthen external research...
Astellas Pharma, Autobahn Labs Partnership Strengthens R&D
Astellas Pharma has entered a strategic partnership with Autobahn Labs to accelerate the translation of academic research into novel drug discovery and development programs,...
Zealand Pharma, OTR Therapeutics Sign Collaboration Deal
Zealand Pharma, OTR Therapeutics sign collaboration through a strategic collaboration and license agreement to discover and develop new therapies for metabolic diseases. The deal...
FDA Approves Inebilizumab-cdon for gMG Treatment in Adults
The U.S. Food and Drug Administration (FDA) has approved inebilizumab-cdon (Uplizna; Amgen) for the treatment of adults with generalized myasthenia gravis who are anti-acetylcholine...
FDA Approval of Gonorrhea Medications Broadens Oral Options
The U.S. Food and Drug Administration has approved two new oral medicines for the treatment of uncomplicated urogenital gonorrhea, marking an important regulatory step...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...



























